11th Floor Central West Wing

Nurses Residence

Chris Hani Baragwanath Hospital

Diepkloof, Soweto

Phone: 011 983 4260

Fax: 086 646 4208

E-mail: vanvurent@rmpru.co.za


1. Madhi SA, Heera JR, Kuwanda L, Klugman KP. Procalcitonin and C-reactive protein estimations improve the specificity of pneumococcal conjugate vaccine efficacy estimates against pneumonia. PLosMedicine. 2005: e38.

2. Madhi SA, Cutland C, Kuwanda L, Klugman KP. The impact of a 9-valent pneumococcal conjugate vaccine on the public health burden of pneumonia in HIV infected and uninfected children. Clin Infect Dis 2005; 40:1511-1518

3. Madhi SA, Kuwanda L, Cutland C, Holm A, Käyhty H, Klugman KP. Quantitative and qualitative antibody response to pneumococcal conjugate vaccine among African HIV infected and uninfected children. Ped Infect Dis J 2005; 24: 410-416.

4. Cherian T, Mulholland KE, Carlin JB, Ostensen H, Amin R, de Campo M, Greenberg D, Lagos R, Lucero M, Madhi SA, O’Brien KL, Obaro S, Steinhoff MC and the W.H.O. Radiology Working Group. Standardised Interpretation of Paediatric Chest Radiographs for the Diagnosis of Pneumonia in Epidemiological Studies.  Bulletin of WHO 2005; 83: 353-359.

5. Zar HJ, Jeena P, Argent A, Gie R, Madhi SA. Diagnosis and Management of Community Acquired Pneumonia in Childhood – South African Thoracic Society guidelines. S Afr Med J 2005; 95: 977-81, 984-90.

6. Ludewick HP, Abed Y, van Niekerk N, Klugman KP, Boivin G and Madhi SA,

      Genetic variability of the human metapneumovirus in South Africa. Emerg Infect  

      Dis J. 2005; 11: 1074-8.  

7. Madhi SA, Kuwanda L, Saarinen L, Cutland C, Mothupi R, Käyhty H, Klugman

      KP. Immunogenicity and effectiveness of Haemophilus influenzae type b

      conjugate vaccine in HIV infected and -uninfected African children. Vaccine  

     2005; 23: 5517-5525.



8. Madhi SA, Kohler M, Kuwanda L; Cutland C; Klugman KP. Usefulness of C-reactive protein to define pneumococcal conjugate vaccine efficacy in the prevention of pneumonia. Pediatr Infect Dis J 2006; 25: 30-36.

9. Wright PF, Karron RA, Madhi SA, Treanor JJ, King JC, O’Shea A, Ikizler MR, Zhu Y, Collins PL, Cutalnd C, Randolph VB, Deatly A, Gruber WC, Murphy BR.  The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans J.Infect Dis.2006; 193:573-81.

10. Van Rie A, Madhi SA, Heera JR, Meddows-Taylor S, Wendelboe AM, Anthony F, Violari A, Tiemessen CT. Influence of intrauterine exposure to Human Immunodeficiency Virus on infant interferon gamma production to BCG and Mycobacterium tuberculosis antigens. Clin Vaccine Immunol .2006; 13:246-252.

11. Madhi SA, Cutland C, Zhu Y, Hackell JG, Newman F, Blackburn N, Murphy BR, Belshe RB, Karron RA, Deatly A, Gruber WC, Wright PF. Transmissibility, infectivity and immunogenicity of a live human parainfluenza type 3 virus vaccine (HPIV3cp45) among susceptible infants and toddlers. Vaccine. 2006; 24: 2432-2439.

12. Madhi SA, Ludewick H, Kuwanda L, van Niekerk N, Cutland C, Little T, Klugman KP. Pneumococcal co-infection with human metapneumovirus. Journal of Infectious Diseases. 2006; 193:1236-43.

13. Madhi SA, Kuwanda L, Cutland C, Klugman KP. Five-year cohort study of hospitalization for respiratory syncytial virus associated lower respiratory tract infection in African children. J Clin Virology 2006; 36: 215-21.

14. Levine OS, O’Brien KL, Knoll M, Adegbola RA, Black S, Cherian T, Dagan R,  Goldblatt D, Grange A, Greenwood B, Hennessy T, Klugman K, Madhi SA, Mulholland K, Nohynek H, Santosham M, Saha SK, Scott AJ, Sow S, Whitney C, Cutts F. Pneumococcal vaccination in developing countries. Lancet 2006; 367: 1880-2.

15. von Gottberg A, de Gouveia L, Madhi SA, du Plessis M, Quan V, Soma K, Huebner R, Flannery B, Schuchat A, Klugman KP and the Group for Enteric, Respiratory and Meningeal Disease Surveillance in South Africa (GERMS-SA) Impact of conjugate Haemophilus influenzae type b (Hib) vaccine introduction in South Africa. Bulletin of WHO 2006; 84:811-818.

16. Obaro S, Madhi SA. Pneumonia Vaccines and Childhood Pneumonia: Are we winning, refining or redefining? Lancet Infect Dis 2006; 6:150-161.

17. Zar H, Madhi SA. Childhood pneumonia- Progress and Challenges. S. Afr Med J.2006; 96:890-900.

<<<<<<Back to Publications